Evidence map›Paper›PMID 36544578›Full record

ArticleNeuro-ophthalmology (Aeolus Press)2022

Multiple Sclerosis: What Methods are Available for the Assessment of Subclinical Visual System Damage?

Demet Yabanoglu, Pinar Topcu-Yilmaz, Murat Irkec, Belgin Kocer, Berna Arli, Ceyla Irkec, Sevilay Karahan

Open access · greenAbstract read
In one paragraph

Article in Neuro-ophthalmology (Aeolus Press), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Demet YabanogluDepartment of Ophthalmology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Pinar Topcu-YilmazDepartment of Ophthalmology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Murat IrkecDepartment of Ophthalmology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Belgin KocerDepartment of Neurology, Gazi University Faculty of Medicine, Ankara, Turkey.
Berna ArliDepartment of Neurology, Gazi University Faculty of Medicine, Ankara, Turkey.
Ceyla IrkecDepartment of Neurology, Gazi University Faculty of Medicine, Ankara, Turkey.
Sevilay KarahanDepartment of Biostatistics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Hacettepe University · TRGazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to assess the visual fields and optical coherence tomography (OCT) measurements in patients with multiple sclerosis (MS) to detect subclinical visual system disease. The study included 15 MS patients with previous optic neuritis (Group I), 17 MS patients without previous optic neuritis (Group II), and 14 healthy controls (Group III). Each subject underwent standard automated perimetry (SAP), frequency doubling technology perimetry (FDTP), and OCT. The mean deviation of SAP in Group I was lower than those in Groups II (p = .018) and III (p = .001). The pattern standard deviation of SAP in Group I was higher than those in Group III (p < .0001). The mean deviation of FDTP in Groups I and II was lower than those in Group III (p = .0001 and p = .016, respectively). The temporal quadrant of the retinal nerve fibre layer in Group I was thinner than those in Groups II and III (p = .005 and p = .003, respectively). The mean macular volume in Group I was thinner than those in Groups II and III (p = .004 and p = .002, respectively). A single method is inadequate for establishing early and/or mild visual impairment in MS. All conventional and non-conventional techniques are complementary in demonstrating subclinical visual damage in MS.

Indexed as

axonal degenerationfrequency-doubling perimetryoptical coherence tomographyoptic neuritisstandard automated perimetrySubclinical multiple sclerosis

Identifiers

PMID36544578
PMCPMC9762815
OpenAlexW4281289861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.